Search results
Found 20 matches for
A feasibility study by Professor James McCullagh shows promise for biomarker discovery using a combination of circulating tumour DNA sequencing and metabolomic analysis.
Funding to compare imaging modalities for liver cancer detection
Liver cancer
15 March 2024
The DeLIVER team will evaluate non-contrast-enhanced MRI and compare it to standard of care ultrasound in a cohort of patients under surveillance for liver cancer.
Oxford DeLIVER research attracts 1000 patients for innovative Pearl clinical study
Liver cancer
29 May 2023
1000 patients have been recruited for the prospective Pearl study within the DeLIVER programme for early liver cancer detection.
Oxford Centre for Early Cancer Detection Symposium 2022 – a recap
Liver cancer Lung cancer OxCODE travel award QResearch SCAN pathway TAPS
4 October 2022
On Tuesday 13th September, the Oxford early cancer detection community gathered at Worcester College to discuss the latest developments in this field, sparking ideas and collaborations for future research.
Cancer at Oxford
Liver cancer Lung cancer Myeloma Pancreatic cancer QResearch SCAN pathway TAPS
29 September 2022
Read about how Oxford's experts are leading the way in cancer prevention, detection and treatment as part of the University's Cancer at Oxford series
First DeLIVER study day
Liver cancer QResearch TAPS
14 June 2022
On Wednesday 8th June 2022, the DeLIVER consortium gathered for the first time to hear about the team’s progress towards the aim of detecting liver cancer earlier.
National clinical study launched to test new technologies for detecting liver cancer
Liver cancer TAPS
25 May 2022
The SELINA study will recruit patients with early liver cancers as part of the DeLIVER programme aiming to detect liver cancer earlier.
First major UK prospective study for liver cancer underway
Liver cancer TAPS
24 February 2022
The Pearl clinical study will recruit 3000 patients with high-risk conditions for liver cancer with the aim of detecting liver cancer earlier as part of the Cancer Research UK-funded DeLIVER programme.
Comparing models to predict liver cancer in individuals with high-risk conditions
Liver cancer
21 February 2022
Members of the DeLIVER consortium and their collaborators have tested the performance of hepatocellular carcinoma risk prediction models in patients with cirrhosis and cured hepatitis C infection.
DeLIVER programme website launched
Liver cancer
26 January 2022
Visit the new website to learn more about the CRUK-funded Early Detection of Hepatocellular Liver Cancer (DeLIVER) programme
TAPS for cancer detection
Liver cancer TAPS
1 September 2021
TAPS technology has been optimised for mapping DNA methylation on circulating cell-free DNA.
Ludwig-Oxford Symposium on Cancer Early Detection and Epigenetics – a recap
Liver cancer TAPS
7 May 2021
On 28-29th April 2021, we heard the latest developments from international leaders in these fields from the University of Oxford, Ludwig Cancer Research and beyond.
DeLIVER clinical research study underway
Liver cancer
23 March 2021
The DELPHI project, one of three clinical studies within the DeLIVER programme for early detection of liver cancer, has started recruiting patients.
Studying viral genetics to aid liver cancer early detection
Liver cancer
15 February 2021
Professor Ellie Barnes and Dr Azim Ansari receive funding to identify cancer-associated genotypes of hepatitis C in Pakistan to improve assessment of liver cancer risk.
Investigating the effects of co-morbidities on liver cancer risk
Liver cancer
15 December 2020
Dr Philippa Matthews and colleagues review the associations between liver cancer risk and co-morbidities and other metabolic factors in individuals with chronic hepatitis B virus infection.
Collating clinical data for liver disease research
Liver cancer
2 December 2020
The NIHR Health Informatics Collaborative Viral Hepatitis theme led by Professor Ellie Barnes has developed a pipeline to build a database of electronic clinical data that can support research into viral hepatitis and associated liver complications.
CRUK Oxford Centre Symposium 2020
Liver cancer Lung cancer
27 October 2020
Oxford’s early detection research is highlighted at this year’s virtual gathering of the Oxford cancer community.
Professor Ellie Barnes comments on the 2020 Nobel Prize for Medicine
Liver cancer
7 October 2020
Professor Ellie Barnes comments on the recent Nobel Prize in Medicine, awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of the Hepatitis C virus, a major global health problem and a cause of cancer.
Urine-based test for accurately assessing fatty liver disease
Liver cancer
7 May 2020
Prof Jeremy Tomlinson leads a study to identify non-invasive biomarkers for diagnosing and staging non-alcoholic fatty liver disease.
Funding success for liver cancer early detection
Liver cancer QResearch TAPS
20 January 2020
Professor Ellie Barnes and her team win a prestigious Cancer Research UK Early Detection Programme Award to research the earlier detection of hepatocellular carcinoma.
Identification of circulating genomic and metabolic biomarkers of bile duct cancer
Liver cancer
17 December 2019
A feasibility study by Professor James McCullagh shows promise for biomarker discovery using a combination of circulating tumour DNA sequencing and metabolomic analysis.